相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey
Emmanuel Chide Okocha et al.
FRONTIERS IN GENETICS (2022)
Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings
Staci Martin et al.
NEUROPSYCHOLOGICAL REHABILITATION (2020)
Universal screening for social determinants of health in pediatric sickle cell disease: A quality-improvement initiative
Alexandra Power-Hays et al.
PEDIATRIC BLOOD & CANCER (2020)
Effective use of hydroxyurea for sickle cell anemia in low-resource countries
Alexandra Power-Hays et al.
CURRENT OPINION IN HEMATOLOGY (2020)
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects
Julie Kanter et al.
BLOOD ADVANCES (2020)
Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study
Jason R. Hodges et al.
BLOOD ADVANCES (2020)
Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia
Lori E. Crosby et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2019)
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study
Kristina Curtis et al.
JMIR MHEALTH AND UHEALTH (2019)
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study
Lakshmanan Krishnamurti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Jo Howard et al.
BLOOD (2019)
Improving Uptake of Hydroxyurea in Patients with Sickle Cell Disease: A Retrospective Study of a Clinic-based Change in Consenting Practices
Aimee W. Smith et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2019)
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa
Leon Tshilolo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis
Kemar Prussien et al.
JOURNAL OF PEDIATRIC PSYCHOLOGY (2019)
L-Glutamine for sickle cell anemia: more questions than answers
Charles T. Quinn
BLOOD (2018)
Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent
Paolo Rigano et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle Cell Anemia
Lydia H. Pecker et al.
JOURNAL OF PEDIATRICS (2018)
A Phase 3 Trial of L-Glutamine in Sickle Cell Disease
Yutaka Niihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea
Cynthia B. Sinha et al.
PLOS ONE (2018)
A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study
Lewis L. Hsu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)
Ahmed A. Daak et al.
BLOOD ADVANCES (2018)
Utilizing a Novel Mobile Health Selfie Application to Improve Compliance to Iron Chelation in Pediatric Patients Receiving Chronic Transfusions
Sarah Leonard et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sickle Cell Disease
Frederic B. Piel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study
Nancy S. Green et al.
PEDIATRIC BLOOD & CANCER (2017)
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study
Robert Molokie et al.
PLOS MEDICINE (2017)
Improving Medication Adherence with Two-way Short Message Service Reminders in Sickle Cell Disease and Asthma A feasibility randomized controlled trial
Brandi M. Pernell et al.
APPLIED CLINICAL INFORMATICS (2017)
NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease
Joshua J. Field et al.
PLOS ONE (2017)
Standard measures for sickle cell disease research: the PhenX Toolkit sickle cell disease collections
James R. Eckman et al.
BLOOD ADVANCES (2017)
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease
Joshua J. Field et al.
BLOOD ADVANCES (2017)
Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial
Carolyn Hoppe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT
Courtney D. Fitzhugh et al.
BLOOD ADVANCES (2017)
Effects of hydroxyurea treatment for patients with hemoglobin SC disease
Lori Luchtman-Jones et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania
Abel Makubi et al.
BMC MEDICAL RESEARCH METHODOLOGY (2016)
Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study
Susumu Inoue et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease
Sherif M. Badawy et al.
PEDIATRIC BLOOD & CANCER (2016)
Hydroxyurea therapy for sickle cell anemia
Patrick T. McGann et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: A cross sectional study
Titilope A. Adeyemo et al.
PEDIATRIC BLOOD & CANCER (2015)
Medication Adherence Measures: An Overview
Wai Yin Lam et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Self-report measures of medication adherence behavior: recommendations on optimal use
Michael J. Stirratt et al.
TRANSLATIONAL BEHAVIORAL MEDICINE (2015)
Sickle cell disease: a neglected chronic disease of increasing global health importance
Subarna Chakravorty et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia
Jeffrey D. Lebensburger et al.
JOURNAL OF BLOOD MEDICINE (2015)
Hydroxycarbamide treatment in sickle cell disease: estimates of possible leukaemia risk and of hospitalization survival benefit
Oswaldo Castro et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
M. R. DeBaun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Pilot Study of Electronic Directly Observed Therapy to Improve Hydroxyurea Adherence in Pediatric Patients With Sickle-Cell Disease
Susan E. Creary et al.
PEDIATRIC BLOOD & CANCER (2014)
Improved Hydroxyurea Effect With the Use of Text Messaging in Children With Sickle Cell Anemia
Jeremie H. Estepp et al.
PEDIATRIC BLOOD & CANCER (2014)
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial
Ofelia Alvarez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease
Clarisse Lopes de Castro Lobo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Hydroxyurea treatment of children with hemoglobin SC disease
Amber M. Yates et al.
PEDIATRIC BLOOD & CANCER (2013)
Parental and Other Factors Associated With Hydroxyurea Use for Pediatric Sickle Cell Disease
Suzette O. Oyeku et al.
PEDIATRIC BLOOD & CANCER (2013)
Adult Emergency Department Patients With Sickle Cell Pain Crisis: Results From a Quality Improvement Learning Collaborative Model to Improve Analgesic Management
Paula Tanabe et al.
ACADEMIC EMERGENCY MEDICINE (2012)
Impact of hydroxyurea on clinical events in the BABY HUG trial
Courtney D. Thornburg et al.
BLOOD (2012)
Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management
Samir K. Ballas et al.
SCIENTIFIC WORLD JOURNAL (2012)
Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease
Carlton Haywood et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Pain management in children and adolescents with sickle cell disease
Jeanette M. Jerrell et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
NEUROCOGNITIVE TESTING AND FUNCTIONING IN ADULT SICKLE CELL DISEASE
Miriam H. Feliu et al.
HEMOGLOBIN (2011)
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
Magnus Bjorkholm et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Winfred C. Wang et al.
LANCET (2011)
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
Martin H. Steinberg et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
分享论文
